|  | Model 1 | Model 2 | ||||
---|---|---|---|---|---|---|---|
Variable | All patients (n = 146) | Low PA level (n = 73) | High PA level (n = 73) | p-value* | Low PA level (n = 49) | High PA level (n = 97) | p-value* |
Age, years (mean, SD) | 81.3 (6.8) | 82.4 (6.6) | 80.2 (6.9) | .896 | 82.0 (6.8) | 81.0 (6.8) | .363 |
Sex (n, %) | Â | Â | Â | .737 | Â | Â | .169 |
 Female | 60 (41.1%) | 29 (39.7%) | 31 (42.5%) |  | 24 (49.0%) | 36 (37.1%) |  |
Average min. standing/walking per day (median, IQR) | 64.4 (34.7 – 100.1) | 34.8 (16.9 – 51.8) | 98.7 (78.1 –136.6) |  < .001 | 24.4 (9.2 – 35.5) | 84.6 (64.4 –124.9) |  < .001 |
SPPB (median, IQR) | 4 (2 – 8) | 3 (1 – 5) | 7 (4 – 10) |  < .001 | 2 (0 – 3) | 6 (4 – 10) |  < .001 |
AM-PAC (n, %) |  |  |  |  < .001 |  |  |  < .001 |
 ≤ 19 | 57 (39.0%) | 44 (60.3%) | 13 (17.8%) |  | 36 (73.5%) | 21 (21.6%) |  |
 20 | 89 (61.0%) | 29 (39.7%) | 60 (82.2%) |  | 13 (26.5%) | 76 (78.4%) |  |
Katz ADL (n, %) |  |  |  | .045 |  |  |  < .001 |
 0 disabilities | 82 (56.2%) | 35 (47.9%) | 47 (64.4%) |  | 17 (34.7%) | 65 (67.0%) |  |
 ≥ 1 disabilities | 64 (43.8%) | 38 (52.1%) | 26 (35.6%) |  | 32 (65.3%) | 32 (33.0%) |  |
Walking aid (n, %) | Â | Â | Â | .038 | Â | Â | .001 |
 None | 79 (54.1%) | 32 (43.8%) | 47 (64.4%) |  | 16 (32.7%) | 63 (64.9%) |  |
 Walker | 49 (33.6%) | 31 (42.5%) | 18 (24.7%) |  | 26 (53.1%) | 23 (23.7%) |  |
 Crutch or cane | 18 (12.3%) | 10 (13.7%) | 8 (11.0%) |  | 7 (14.3%) | 11 (11.3%) |  |
Clinical diagnosis (n, %) | Â | Â | Â | .065 | Â | Â | .120 |
 Digestive | 35 (24.0%) | 15 (20.5%) | 20 (27.4%) |  | 9 (18.4%) | 26 (26.8%) |  |
 Respiratory | 27 (18.5%) | 10 (13.7%) | 17 (23.3%) |  | 7 (14.3%) | 20 (20.6%) |  |
 Infectious | 23 (15.8%) | 17 (23.3%) | 6 (8.2%) |  | 13 (26.5%) | 10 (10.3%) |  |
 Neoplasms | 16 (11.0%) | 10 (13.7%) | 6 (8.2%) |  | 7 (14.3%) | 9 (9.3%) |  |
 Genitourinary | 14 (9.6%) | 9 (12.3%) | 5 (6.8%) |  | 3 (6.1%) | 11 (11.3%) |  |
 Circulatory | 7 (4.8%) | 2 (2.7%) | 5 (6.8%) |  | 1 (2.0%) | 6 (6.2%) |  |
 Other | 24 (16.4%) | 10 (13.7%) | 14 (19.2%) |  | 9 (18.4%) | 15 (15.5%) |  |
Comorbidities (CCI) (median, IQR) | 2 (1 – 4) | 3 (1 – 4) | 2 (1 – 3) | .064 | 3 (1.5 – 5) | 2 (1 – 3) | .001 |
Nr. of falls ≤ 6 months (median, IQR) | 0 (0—1) | 0 (0 – 2) | 0 (0 – 1) | .386 | 0 (0 – 2) | 0 (0 – 1) | .086 |
PT consulted (n, %) |  |  |  |  < .001 |  |  |  < .001 |
 Yes | 89 (61.0%) | 55 (75.3%) | 34 (46.6%) |  | 40 (81.6%) | 49 (50.5%) |  |
 No | 57 (39.0%) | 18 (24.7%) | 39 (53.4%) |  | 9 (18.4%) | 48 (49.5%) |  |
LOS, days (median, IQR) | 9 (6 – 13) | 11 (7 – 15) | 8 (6 – 11) | .001 | 13 (8 – 17) | 8 (6 – 11) |  < .001 |
Discharge location (n, %) |  |  |  | .001 |  |  |  < .001 |
 Home | 119 (81.5%) | 50 (68.5%) | 69 (94.5%) |  | 29 (59.2%) | 90 (92.8%) |  |
 Geriatric rehabilitation centre | 16 (11.0%) | 13 (17.8%) | 3 (4.1%) |  | 12 (24.5%) | 4 (4.1%) |  |
 Nursing home | 6 (4.1%) | 5 (6.8%) | 1 (1.4%) |  | 3 (6.1%) | 3 (3.1%) |  |
 Other | 5 (3.4%) | 5 (6.8%) | 0 (0.0%) |  | 5 (10.2%) | 0 (0.0%) |  |